Business Medical Dialogues
    • facebook
    • twitter
    Login Register
    • facebook
    • twitter
    Login Register
    • Medical Dialogues
    • Speciality Dialogues
    • Education Dialogues
    • Medical Jobs
    • Medical Matrimony
    • MD Brand Connect
    Business Medical Dialogues
    • News
        • Financial Results
        • Hospitals & Diagnostics
        • IT / Health Venture
        • Implants / Devices
        • Insurance
        • Key Movement
        • Pharmaceuticals
        • Policy
        • Technology
        • pharma-news
    • blog
    LoginRegister
    Business Medical Dialogues
    LoginRegister
    • Home
    • News
      • Financial Results
      • Hospitals & Diagnostics
      • IT / Health Venture
      • Implants / Devices
      • Insurance
      • Key Movement
      • Pharmaceuticals
      • Policy
      • Technology
      • pharma-news
    • blog
    • Home
    • Latest News
    • Strides Shasun plans...

    Strides Shasun plans to divest British subsidiary for Rs 240 crore

    Written by savita thakur thakur Published On 2016-05-18T15:56:14+05:30  |  Updated On 18 May 2016 3:56 PM IST

    New Delhi : Drug firm Strides Shasun has decided to divest the company's UK arm Shasun Pharma Solutions Ltd to its current management for an enterprise value of GBP 25 million (over Rs 240 crore). "The board of directors of the company at their meeting held today approved the divestment of SPSL, UK to the current management team of SPSL with funding by the promoter group of Strides Shasun for an enterprise value of GBP 25 million", Strides Shasun said in a filing to BSE. Shasun had acquired SPSL from Rhodia in 2006.


    Since 2014 the current management of SPSL has shifted focus from being a pure CRAMS player to multiple industry CRAMS business including services, it added. "The transaction is expected to achieve closure in the second quarter of FY 17," Strides Shasun said adding that the transaction will be at arms length basis. In another filing Strides Shasun said its wholly owned subsidiary in Australia, Arrow Pharmaceuticals Pty Ltd has "entered into a 10-year supply partnership and trading platform with Pharmacy Alliance".

    The new agreement also includes investment by Arrow in Pharmacy Alliance's plans for growth and retail innovation. The supply agreement is an extension to the existing supply arrangement previously in place between Pharmacy Alliance and Aspen, before the Aspen Generics & Chemists' Own business was acquired by Arrow in September 2015.
    Arrow PharmaCRAMSSPSLStrides Shasun
    Source : PTI

    Disclaimer: This site is primarily intended for healthcare professionals. Any content/information on this website does not replace the advice of medical and/or health professionals and should not be construed as medical/diagnostic advice/endorsement or prescription. Use of this site is subject to our terms of use, privacy policy, advertisement policy. © 2020 Minerva Medical Treatment Pvt Ltd

    savita thakur thakur
    savita thakur thakur
      Show Full Article
      Next Story
      Similar Posts
      NO DATA FOUND

      Popular Stories

      • Email: info@medicaldialogues.in
      • Phone: 011 - 4372 0751

      Website Last Updated On : 13 Oct 2022 5:14 AM GMT
      Company
      • About Us
      • Contact Us
      • Our Team
      • Reach our Editor
      • Feedback
      • Submit Article
      Ads & Legal
      • Advertise
      • Advertise Policy
      • Terms and Conditions
      • Privacy Policy
      • Editorial Policy
      • Comments Policy
      • Disclamier
      Medical Dialogues is health news portal designed to update medical and healthcare professionals but does not limit/block other interested parties from accessing our general health content. The health content on Medical Dialogues and its subdomains is created and/or edited by our expert team, that includes doctors, healthcare researchers and scientific writers, who review all medical information to keep them in line with the latest evidence-based medical information and accepted health guidelines by established medical organisations of the world.

      Any content/information on this website does not replace the advice of medical and/or health professionals and should not be construed as medical/diagnostic advice/endorsement or prescription.Use of this site is subject to our terms of use, privacy policy, advertisement policy. You can check out disclaimers here. © 2025 Minerva Medical Treatment Pvt Ltd

      © 2025 - Medical Dialogues. All Rights Reserved.
      Powered By: Hocalwire
      X
      We use cookies for analytics, advertising and to improve our site. You agree to our use of cookies by continuing to use our site. To know more, see our Cookie Policy and Cookie Settings.Ok